Ronan J. Kelly

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly, Jaffer A. Ajani, Thomas Zander et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Medicine, Oncology, Surgery +14

Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma

Elizabeth D. Thompson, Marianna Zahurak, Adrian Murphy et al. · Gut · 2016 · 495 citations

Medicine, Oncology, Pathology +17

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

David Planchard, Tae Min Kim, Julien Mazières et al. · The Lancet Oncology · 2016 · 444 citations · Full text

Medicine, Oncology, Pharmacology +8

Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors

Karthik Suresh, Khinh Ranh Voong, Bairavi Shankar et al. · Journal of Thoracic Oncology · 2018 · 431 citations · Full text

Life Sciences, Immunology, Oncology +14

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis

David Planchard, Benjamin Besse, Harry J.M. Groen et al. · Journal of Thoracic Oncology · 2021 · 269 citations · Full text

Medicine, Oncology, Pharmacology +14